Abstract
Cognitive impairment is prevalent in multiple sclerosis (MS) occurring in 43–72 % of patients with all MS phenotypes. The aim of our study was to assess cognitive performance in different MS subtypes in Serbian population. Rao’s Brief Repeatable Battery of neuropsychological tests (BRB-N) was administered to 168 MS patients [37 patients with clinically isolated syndrome (CIS) suggestive of MS, 65 with relapsing-remitting MS (RRMS), 31 with secondary progressive MS (SPMS) and 35 patients with primary progressive MS (PPMS)]. The percentage of cognitively impaired patients in our total MS cohort was 58.9 %. Prevalence of cognitive dysfunction was 40.5 % in CIS group, 36.9 % in RRMS, 96.8 % in SPMS, and 85.7 % in PPMS group. Patients in CIS and RRMS groups performed consistently better all tests of the Rao’s battery than patients in SPMS and PPMS cohort. CIS and RRMS groups performed consistently better in all tests of the Rao’s battery than SPMS and PPMS cohort. Additionally, difference in the performance of any of the BRB-N tests was not found between CIS and RRMS. However, there was a significant difference between SPMS and PPMS patients in the performance on five tests of Rao’s battery. Statistical significance (p < 0.05) in favor of PPMS patients was demonstrated for the following tasks: SRT_lts, SRT_cltr, SDMT, SRT_D, SPART_D. Our study demonstrates that cognitive impairment is frequent in all MS phenotypes. Furthermore, we have found that cognitive deficit is most severe and most frequent in SPMS patients, followed by PPMS subjects and then CIS and RRMS patients.
Similar content being viewed by others
References
Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41(5):685–691
Peyser JM, Edwards KR, Poser CM, Filskov SB (1980) Cognitive function in patients with multiple sclerosis. Arch Neurol 37(9):577–579
Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151
Langdon DW (2011) Cognition in multiple sclerosis. Curr Opin Neurol 24(3):244–249
Prakash RS, Snook EM, Lewis JM, Motl RW, Kramer AF (2008) Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis. Mult Scler 14(9):1250–1261
Rao SM and the Cognitive Function Study Group of the National Multiple Sclerosis Society (1990) A manual for the Brief Repeatable Battery of neuropsychological tests in multiple sclerosis. Medical College of Wisconsin, Milwaukee
Benedict RH, Fischer JS, Archibald CJ, Arnett PA, Beatty WW, Bobholz J, Chelune GJ, Fisk JD, Langdon DW, Caruso L, Foley F, LaRocca NG, Vowels L, Weinstein A, DeLuca J, Rao SM, Munschauer F (2002) Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 16(3):381–397
Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B (2006) Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 12(12):549–558
Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hämäläinen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RH (2012) Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 18(6):891–898
Arnett PA, Barwick FH, Beeney JE (2008) Depression in multiple sclerosis: review and theoretical proposal. Int Neuropsychol Soc 14(5):691–724
Arnett PA (2005) Longitudinal consistency of the relationship between depression symptoms and cognitive functioning in multiple sclerosis. CNS Spectr 10(5):372–382
Landro NI, Celius EG, Sletvold H (2004) Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis. J Neurol Sci 217(2):211–216
DeLuca J, Barbieri-Berger S, Johnson SK (1994) The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 16(2):183–189
Sundgren M, Maurex L, Wahlin Å, Piehl F, Brismar T (2013) Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis. Arch Clin Neuropsychol 28(2):144–155
Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Polman CH (2006) Cognitive impairment and decline in different MS subtypes. J Neurol Sci 245(1–2):187–194
Denney DR, Sworowski LA, Lynch SG (2005) Cognitive impairment in three subtypes of multiple sclerosis. Arch Clin Neuropsychol 20(8):967–981
Ruggieri RM, Palermo R, Vitello G, Gennuso M, Settipani N, Piccoli F (2003) Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurol Scand 108(5):323–326
Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Amato MP (2010) Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 16(1):62–67
Mesaros S, Rocca MA, Riccitelli G, Pagani E, Rovaris M, Caputo D, Ghezzi A, Capra R, Bertolotto A, Comi G, Filippi M (2009) Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp 30(8):2656–2666
Obradovic D, Petrovic M, Antanasijevic I, Marinkovic J, Stojanovic T, Obradovic S (2012) The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population. Neurol Sci 33(6):1369–1374
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the “McDonald Criteria”. Ann Neurol 69(2):292–302
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278–286
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
Beck AT, Beck RW (1972) Screening depressed patients in family practice. A rapid technic. Postgrad Med 52(6):81–85
Buschke H, Fuld PA (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24(11):1019–1025
Barbizet J, Cany E (1968) Clinical and psychometrical study of a patient with memory disturbances. Int J Neurol 7(1):44–54
Smith A (1982) Symbol digits modalities test. Western Psychological Services, Los Angeles
Gronwall DM (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44(2):367–373
Amato MP, Portaccio E, Goretti B, Zipoli V, Iudice A, Della Pina D, Malentacchi G, Sabatini S, Annunziata P, Falcini M, Mazzoni M, Mortilla M, Fonda C, De Stefano N, TuSCIMS Study Group (2010) Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 16(12):1474–1482
Sepulcre J, Vanotti S, Hernández R, Sandoval G, Cáceres F, Garcea O, Villoslada P (2006) Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-neuropsychology test. Mult Scler 12(2):187–195
Solari A, Mancuso L, Motta A, Mendozzi L, Serrati C (2002) Comparison of two brief neuropsychological batteries in people with multiple sclerosis. Mult Scler 8(2):169–176
Gaudino EA, Chiaravalloti ND, DeLuca J, Diamond BJ (2001) A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Neuropsychiatr Neuropsychol Behav Neurol 14(1):32–44
Huijbregts SC, Kalkers NF, de Sonneville LM, de Groot V, Reuling IE, Polman CH (2004) Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 63(2):335–339
Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D (2008) Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267(1–2):100–106
Ruet A, Deloire M, Charre-MorinJ Hamel D, Brochet B (2013) Cognitive impairment differs between primary progressive and relapsing- remitting MS. Neurology 80(16):1501–1508
Rosti-Otajärvi E, Ruutiainen J, Huhtala H, Hämäläinen P (2014) Cognitive performance profile in different phenotypes of MS with cognitive complaints. Mult Scler Relat Disord 3(4):463–472
Feuillet L, Reuter F, Audoin B, Malikova I, Barrau K, Cherif AA, Pelletier J (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 13(1):124–127
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group (2009) Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the cognitive impairment in multiple sclerosis (COGIMUS) study. Mult Scler 15(7):779–788
Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M, MAGNIMS Study Group (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14(3):302–317
Sumowski JF, Rocca MA, Leavitt VM, Dackovic J, Mesaros S, Drulovic J, DeLuca J, Filippi M (2014) Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS. Neurology 82(20):1776–1783
Acknowledgments
This investigation was supported by the Ministry of Education, Science and Technologic Development of the Republic of Serbia (Grant Nos 175031 and 175087).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dackovic, J., Pekmezovic, T., Mesaros, S. et al. The Rao’s Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population. Neurol Sci 37, 1475–1481 (2016). https://doi.org/10.1007/s10072-016-2610-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2610-1